nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—DRD4—conduct disorder	0.616	0.685	CbGaD
Promazine—HTR2A—conduct disorder	0.284	0.316	CbGaD
Promazine—Propiomazine—DRD4—conduct disorder	0.000411	0.0586	CrCbGaD
Promazine—Cyamemazine—HTR2A—conduct disorder	0.000369	0.0526	CrCbGaD
Promazine—Methotrimeprazine—DRD4—conduct disorder	0.000351	0.0501	CrCbGaD
Promazine—Cyclobenzaprine—HTR2A—conduct disorder	0.000343	0.0489	CrCbGaD
Promazine—Quetiapine—DRD4—conduct disorder	0.000331	0.0472	CrCbGaD
Promazine—Chlorphenamine—SLC6A4—conduct disorder	0.000312	0.0445	CrCbGaD
Promazine—Chlorpromazine—DRD4—conduct disorder	0.000268	0.0382	CrCbGaD
Promazine—Acepromazine—HTR2A—conduct disorder	0.000237	0.0338	CrCbGaD
Promazine—Clomipramine—SLC6A4—conduct disorder	0.000234	0.0334	CrCbGaD
Promazine—Thioproperazine—HTR2A—conduct disorder	0.000232	0.033	CrCbGaD
Promazine—Pipotiazine—HTR2A—conduct disorder	0.000228	0.0325	CrCbGaD
Promazine—Mesoridazine—HTR2A—conduct disorder	0.000225	0.0321	CrCbGaD
Promazine—Trimipramine—SLC6A4—conduct disorder	0.000216	0.0308	CrCbGaD
Promazine—Doxepin—SLC6A4—conduct disorder	0.000206	0.0293	CrCbGaD
Promazine—Fluphenazine—HTR2A—conduct disorder	0.000197	0.0281	CrCbGaD
Promazine—Propiomazine—HTR2A—conduct disorder	0.00019	0.027	CrCbGaD
Promazine—Desipramine—SLC6A4—conduct disorder	0.000189	0.0269	CrCbGaD
Promazine—Clomipramine—HTR2A—conduct disorder	0.00018	0.0257	CrCbGaD
Promazine—Chlorprothixene—HTR2A—conduct disorder	0.000179	0.0256	CrCbGaD
Promazine—Thioridazine—HTR2A—conduct disorder	0.00017	0.0242	CrCbGaD
Promazine—Trimipramine—HTR2A—conduct disorder	0.000166	0.0236	CrCbGaD
Promazine—Methotrimeprazine—HTR2A—conduct disorder	0.000162	0.0231	CrCbGaD
Promazine—Imipramine—SLC6A4—conduct disorder	0.00016	0.0228	CrCbGaD
Promazine—Promethazine—HTR2A—conduct disorder	0.00016	0.0228	CrCbGaD
Promazine—Amitriptyline—SLC6A4—conduct disorder	0.000159	0.0227	CrCbGaD
Promazine—Doxepin—HTR2A—conduct disorder	0.000158	0.0225	CrCbGaD
Promazine—Trifluoperazine—HTR2A—conduct disorder	0.000157	0.0225	CrCbGaD
Promazine—Perphenazine—HTR2A—conduct disorder	0.000156	0.0222	CrCbGaD
Promazine—Quetiapine—HTR2A—conduct disorder	0.000153	0.0218	CrCbGaD
Promazine—Desipramine—HTR2A—conduct disorder	0.000145	0.0207	CrCbGaD
Promazine—Chlorpromazine—HTR2A—conduct disorder	0.000124	0.0176	CrCbGaD
Promazine—Imipramine—HTR2A—conduct disorder	0.000123	0.0175	CrCbGaD
Promazine—Amitriptyline—HTR2A—conduct disorder	0.000122	0.0174	CrCbGaD
Promazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000118	0.00127	CbGpPWpGaD
Promazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000116	0.00126	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000113	0.00122	CbGpPWpGaD
Promazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000112	0.00121	CbGpPWpGaD
Promazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000112	0.00121	CbGpPWpGaD
Promazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000112	0.00121	CbGpPWpGaD
Promazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000112	0.00121	CbGpPWpGaD
Promazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000112	0.00121	CbGpPWpGaD
Promazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000111	0.00121	CbGpPWpGaD
Promazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000111	0.0012	CbGpPWpGaD
Promazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00011	0.00119	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00117	CbGpPWpGaD
Promazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.00116	CbGpPWpGaD
Promazine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.00116	CbGpPWpGaD
Promazine—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000107	0.00116	CbGpPWpGaD
Promazine—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000106	0.00115	CbGpPWpGaD
Promazine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.00114	CbGpPWpGaD
Promazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000103	0.00111	CbGpPWpGaD
Promazine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000103	0.00111	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000103	0.00111	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.97e-05	0.00108	CbGpPWpGaD
Promazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.88e-05	0.00107	CbGpPWpGaD
Promazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.88e-05	0.00107	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	9.82e-05	0.00106	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.81e-05	0.00106	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	9.79e-05	0.00106	CbGpPWpGaD
Promazine—CYP2C9—Biological oxidations—COMT—conduct disorder	9.76e-05	0.00106	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	9.75e-05	0.00105	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	9.72e-05	0.00105	CbGpPWpGaD
Promazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.72e-05	0.00105	CbGpPWpGaD
Promazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.7e-05	0.00105	CbGpPWpGaD
Promazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	9.7e-05	0.00105	CbGpPWpGaD
Promazine—CYP2C9—Biological oxidations—MAOA—conduct disorder	9.69e-05	0.00105	CbGpPWpGaD
Promazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.67e-05	0.00105	CbGpPWpGaD
Promazine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	9.67e-05	0.00105	CbGpPWpGaD
Promazine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.64e-05	0.00104	CbGpPWpGaD
Promazine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	9.64e-05	0.00104	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	9.63e-05	0.00104	CbGpPWpGaD
Promazine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	9.63e-05	0.00104	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	9.6e-05	0.00104	CbGpPWpGaD
Promazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.59e-05	0.00104	CbGpPWpGaD
Promazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.54e-05	0.00103	CbGpPWpGaD
Promazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	9.54e-05	0.00103	CbGpPWpGaD
Promazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.52e-05	0.00103	CbGpPWpGaD
Promazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	9.52e-05	0.00103	CbGpPWpGaD
Promazine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	9.48e-05	0.00103	CbGpPWpGaD
Promazine—DRD4—Circadian rythm related genes—EP300—conduct disorder	9.4e-05	0.00102	CbGpPWpGaD
Promazine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	9.35e-05	0.00101	CbGpPWpGaD
Promazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.18e-05	0.000993	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.11e-05	0.000985	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—CGA—conduct disorder	9.05e-05	0.000979	CbGpPWpGaD
Promazine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	8.96e-05	0.000969	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.92e-05	0.000965	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.91e-05	0.000963	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—CGA—conduct disorder	8.89e-05	0.000961	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—CGA—conduct disorder	8.86e-05	0.000958	CbGpPWpGaD
Promazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.84e-05	0.000956	CbGpPWpGaD
Promazine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.84e-05	0.000956	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—CGA—conduct disorder	8.83e-05	0.000955	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	8.74e-05	0.000946	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	8.72e-05	0.000943	CbGpPWpGaD
Promazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	8.53e-05	0.000923	CbGpPWpGaD
Promazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	8.46e-05	0.000915	CbGpPWpGaD
Promazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.46e-05	0.000915	CbGpPWpGaD
Promazine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	8.42e-05	0.000911	CbGpPWpGaD
Promazine—CYP1A2—Biological oxidations—COMT—conduct disorder	8.34e-05	0.000902	CbGpPWpGaD
Promazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.31e-05	0.000899	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.3e-05	0.000898	CbGpPWpGaD
Promazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.28e-05	0.000896	CbGpPWpGaD
Promazine—CYP1A2—Biological oxidations—MAOA—conduct disorder	8.28e-05	0.000896	CbGpPWpGaD
Promazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.26e-05	0.000893	CbGpPWpGaD
Promazine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	8.23e-05	0.00089	CbGpPWpGaD
Promazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.18e-05	0.000884	CbGpPWpGaD
Promazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.15e-05	0.000882	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	8.1e-05	0.000876	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	8.1e-05	0.000876	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CGA—conduct disorder	7.87e-05	0.000851	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CGA—conduct disorder	7.76e-05	0.000839	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	7.76e-05	0.000839	CbGpPWpGaD
Promazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.7e-05	0.000833	CbGpPWpGaD
Promazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.58e-05	0.000819	CbGpPWpGaD
Promazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	7.56e-05	0.000818	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CGA—conduct disorder	7.43e-05	0.000804	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	7.39e-05	0.000799	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	7.36e-05	0.000796	CbGpPWpGaD
Promazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.3e-05	0.00079	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	7.29e-05	0.000789	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.09e-05	0.000767	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CGA—conduct disorder	7.08e-05	0.000766	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	7.04e-05	0.000762	CbGpPWpGaD
Promazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.99e-05	0.000756	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CGA—conduct disorder	6.99e-05	0.000756	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.71e-05	0.000726	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	6.62e-05	0.000716	CbGpPWpGaD
Promazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.44e-05	0.000697	CbGpPWpGaD
Promazine—CYP3A4—Biological oxidations—COMT—conduct disorder	6.44e-05	0.000696	CbGpPWpGaD
Promazine—CYP3A4—Biological oxidations—MAOA—conduct disorder	6.39e-05	0.000691	CbGpPWpGaD
Promazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.39e-05	0.000691	CbGpPWpGaD
Promazine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.35e-05	0.000687	CbGpPWpGaD
Promazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	6.33e-05	0.000684	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.32e-05	0.000684	CbGpPWpGaD
Promazine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	6.31e-05	0.000682	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—WASF1—conduct disorder	6.3e-05	0.000682	CbGpPWpGaD
Promazine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	6.29e-05	0.00068	CbGpPWpGaD
Promazine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	6.25e-05	0.000676	CbGpPWpGaD
Promazine—CHRM3—Metabolism—CGA—conduct disorder	6.24e-05	0.000675	CbGpPWpGaD
Promazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	6.23e-05	0.000673	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—WASF1—conduct disorder	6.22e-05	0.000673	CbGpPWpGaD
Promazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	6.21e-05	0.000671	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.06e-05	0.000655	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.05e-05	0.000655	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.96e-05	0.000644	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.8e-05	0.000627	CbGpPWpGaD
Promazine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.77e-05	0.000624	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.74e-05	0.000621	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—CGA—conduct disorder	5.72e-05	0.000619	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—WASF1—conduct disorder	5.68e-05	0.000614	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	5.6e-05	0.000606	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.58e-05	0.000604	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.5e-05	0.000595	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.49e-05	0.000594	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.48e-05	0.000593	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	5.46e-05	0.000591	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	5.44e-05	0.000589	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5.39e-05	0.000583	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.38e-05	0.000582	CbGpPWpGaD
Promazine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	5.36e-05	0.000579	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CGA—conduct disorder	5.35e-05	0.000578	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	5.29e-05	0.000572	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.26e-05	0.000569	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CGA—conduct disorder	5.25e-05	0.000568	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CGA—conduct disorder	5.23e-05	0.000566	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CGA—conduct disorder	5.22e-05	0.000564	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CGA—conduct disorder	5.17e-05	0.000559	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	5.15e-05	0.000557	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.07e-05	0.000548	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	5.06e-05	0.000547	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	5e-05	0.00054	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.99e-05	0.000539	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.98e-05	0.000538	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.96e-05	0.000536	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.94e-05	0.000535	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.9e-05	0.00053	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.88e-05	0.000528	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.87e-05	0.000526	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.86e-05	0.000525	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.82e-05	0.000522	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.8e-05	0.000519	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.79e-05	0.000518	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.76e-05	0.000515	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.65e-05	0.000503	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.6e-05	0.000497	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.54e-05	0.000491	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.38e-05	0.000474	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—DRD4—conduct disorder	4.35e-05	0.00047	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	4.32e-05	0.000467	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—WASF1—conduct disorder	4.28e-05	0.000463	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.22e-05	0.000456	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—WASF1—conduct disorder	4.21e-05	0.000455	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—WASF1—conduct disorder	4.19e-05	0.000454	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—WASF1—conduct disorder	4.18e-05	0.000452	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—DRD4—conduct disorder	4.16e-05	0.00045	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	4.14e-05	0.000448	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	4.13e-05	0.000446	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.13e-05	0.000446	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CGA—conduct disorder	4.06e-05	0.000439	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—DRD4—conduct disorder	3.97e-05	0.000429	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.95e-05	0.000427	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.91e-05	0.000423	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.84e-05	0.000415	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.75e-05	0.000405	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CGA—conduct disorder	3.7e-05	0.0004	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.64e-05	0.000394	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.59e-05	0.000388	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.58e-05	0.000387	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.56e-05	0.000385	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.55e-05	0.000384	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.52e-05	0.00038	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.51e-05	0.000379	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.39e-05	0.000367	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.31e-05	0.000358	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.26e-05	0.000353	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.25e-05	0.000351	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.25e-05	0.000351	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	3.24e-05	0.00035	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000349	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	3.19e-05	0.000346	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	3.19e-05	0.000345	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CGA—conduct disorder	3.16e-05	0.000342	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.99e-05	0.000324	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.96e-05	0.00032	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.95e-05	0.000319	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.94e-05	0.000318	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.93e-05	0.000317	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000316	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.89e-05	0.000313	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.88e-05	0.000312	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.87e-05	0.000311	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.84e-05	0.000307	CbGpPWpGaD
Promazine—CHRM3—Metabolism—COMT—conduct disorder	2.82e-05	0.000305	CbGpPWpGaD
Promazine—CHRM3—Metabolism—MAOA—conduct disorder	2.8e-05	0.000302	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—EP300—conduct disorder	2.73e-05	0.000296	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.72e-05	0.000294	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.68e-05	0.00029	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.59e-05	0.00028	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—COMT—conduct disorder	2.58e-05	0.000279	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—MAOA—conduct disorder	2.57e-05	0.000277	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.55e-05	0.000276	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CGA—conduct disorder	2.44e-05	0.000264	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.21e-05	0.000239	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.12e-05	0.000229	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.000211	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.92e-05	0.000207	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000207	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000206	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.89e-05	0.000204	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000204	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—COMT—conduct disorder	1.83e-05	0.000198	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—MAOA—conduct disorder	1.82e-05	0.000197	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.76e-05	0.000191	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.75e-05	0.000189	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—COMT—conduct disorder	1.67e-05	0.000181	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MAOA—conduct disorder	1.66e-05	0.000179	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.61e-05	0.000174	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000165	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EP300—conduct disorder	1.5e-05	0.000162	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EP300—conduct disorder	1.44e-05	0.000156	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—COMT—conduct disorder	1.43e-05	0.000154	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MAOA—conduct disorder	1.42e-05	0.000153	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.37e-05	0.000149	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EP300—conduct disorder	1.37e-05	0.000148	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000146	CbGpPWpGaD
Promazine—CHRM3—Metabolism—EP300—conduct disorder	1.21e-05	0.000131	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.17e-05	0.000127	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000121	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—EP300—conduct disorder	1.11e-05	0.00012	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—COMT—conduct disorder	1.1e-05	0.000119	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MAOA—conduct disorder	1.09e-05	0.000118	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.03e-05	0.000112	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.02e-05	0.00011	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.02e-05	0.00011	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.00011	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000109	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1e-05	0.000108	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.97e-06	0.000108	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EP300—conduct disorder	9.26e-06	0.0001	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—EP300—conduct disorder	7.85e-06	8.49e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—EP300—conduct disorder	7.16e-06	7.74e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—EP300—conduct disorder	6.12e-06	6.61e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—EP300—conduct disorder	4.72e-06	5.11e-05	CbGpPWpGaD
